CD44 and colorectal carcinoma: As shown in Figure 1J–L, abemaciclib treatment in HCT 116 cells significantly suppressed mammosphere formation and decreased the proportion of CD44+/CD133+ cells, which are recognized as markers of CRC CSC population.33, 34